DC STEM Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.

Press releases published on September 22, 2026

Sep. 22, 2026

Skyward Specialty Partners with SnapRefund to Set a New Standard for Claim Payments Using ClaimsSnap

Indeterminate GlobeNewswire

Sep. 22, 2026

Rhythm Pharmaceuticals Announces Health Canada Approval of IMCIVREE® (setmelanotide) for Weight Management in Adult and Pediatric Patients 4 years of Age and Older with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Sep. 22, 2026

Identity Digital Spins Out Known to Advance AI Agent Accountability

Indeterminate GlobeNewswire

Sep. 22, 2026

Recludix Pharma to Present at the Oppenheimer Private Life Sciences Company Showcase

Indeterminate GlobeNewswire

Sep. 22, 2026

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

Indeterminate GlobeNewswire

Sep. 22, 2026

Fine Entertainment Launches El Corazón Investment Offering for Accredited Investors

Indeterminate GlobeNewswire

Sep. 22, 2026

TTEC Launches New Automotive Customer Experience Program in Cairo

Indeterminate GlobeNewswire

Sep. 22, 2026

SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors

Indeterminate GlobeNewswire

Sep. 22, 2026

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

Indeterminate GlobeNewswire

Sep. 22, 2026

Envisagenics and Boehringer Ingelheim Enter Multi-Target Collaboration to Develop First-in-Class Precision Therapies Based on RNA Splicing-Derived Targets for Hard-to-Treat Cancers

Indeterminate GlobeNewswire

Sep. 22, 2026

Encore Appoints Former Royal Canadian Air Force Commander Michael Hood as Strategic Advisor

Indeterminate GlobeNewswire

Sep. 22, 2026

Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

Indeterminate GlobeNewswire

Sep. 22, 2026

SailPoint to Host Analyst and Investor Webcast to Recap Navigate Innovations

Indeterminate GlobeNewswire

Sep. 22, 2026

Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs

Indeterminate GlobeNewswire

Sep. 22, 2026

EagleNXT Provides Update on American-Made Drone and Sensor Shipments from U.S. Headquarters in Allen, Texas

Indeterminate GlobeNewswire

Sep. 22, 2026

Genius Group to host Genius Future Summit on November 5-6, 2026.

Indeterminate GlobeNewswire

Sep. 22, 2026

CIRA’s award-winning ‘What’s up with the internet?’ podcast returns for its fourth season to explore Canada’s creator economy

Indeterminate GlobeNewswire

Sep. 22, 2026

Le balado primé de CIRA « Qu’est-ce qui se passe avec l’Internet? » est de retour pour sa quatrième saison afin d’explorer l’économie du monde de la création de contenu au Canada

Indeterminate GlobeNewswire

Sep. 22, 2026

FactSet Marks a New Era in Enterprise Real-Time Market Data as It Acquires BCC Group International

Indeterminate GlobeNewswire

Sep. 22, 2026

Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens

Indeterminate GlobeNewswire